Goeltz II Robert C. sold RCUS
December 31, 2025 · Form 4 insider transaction
Goeltz II Robert C. sold 6,552 shares of Arcus Biosciences, Inc. at $23.38 per share, a transaction worth $153.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,552
Price
$23.38
Total value
$153.2K
InsiderGoeltz II Robert C.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 31, 2025
Filing dateJanuary 2, 2026
Shares owned after67,924
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.